|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1997;64:1427
© 1997 The Society of Thoracic Surgeons
| The first 20% of the full text of this article appears below. |
See also page 1422.
DR DARROCH W. O. MOORES (Albany, NY): I congratulate Dr Girardi and his colleagues for an excellent presentation and an interesting paper.
This paper, as Dr Girardi stated, presents one surgeon's experience with pericardial effusion over an 8-year period. There were 60 patients who underwent four different procedures.
The title of the paper is somewhat of a misnomer. The procedure carried out is not simple pericardiocentesis, but actually a percutaneous tube pericardiostomy using a small-bore catheter, followed by the instillation of a sclerosing agent. The 13% recurrence rate for the procedure was based on the three failures and the two catheter obstructions.
We reported on 155 patients with both benign and malignant pericardial effusions treated with subxiphoid pericardial drainage. We had a 2.5% recurrence rate; however, there were no recurrences in patients who had a malignant effusion.
Like Dr Girardi and his colleagues, we found survival was significantly longer in patients with pericardial tamponade who had breast cancer. This was particularly so in those patients with a history of breast cancer who did not have malignancy in their pericardium. Therefore, in patients with pericardial
Related Article
Ann. Thorac. Surg. 1997 64: 1422-1427.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |